Dynavax Technologies Corporation
Clinical trials sponsored by Dynavax Technologies Corporation, explained in plain language.
-
New shingles vaccine Z-1018 goes Head-to-Head with shingrix in major trial
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new shingles vaccine called Z-1018 in about 764 healthy adults aged 50 and older. Researchers compare it to the current vaccine, Shingrix, to see if it is safe and triggers a strong immune response. The goal is to find a better way to prevent shingles, a painfu…
Phase: PHASE1, PHASE2 • Sponsor: Dynavax Technologies Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 04:47 UTC
-
New plague vaccine trial aims to protect against deadly infection
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine called rF1V-1018 to see if it is safe and triggers a strong immune response against pneumonic plague, a serious lung infection caused by Yersinia pestis bacteria. About 148 healthy adults aged 18 to 55 will receive the vaccine and be monitored for s…
Phase: PHASE2 • Sponsor: Dynavax Technologies Corporation • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 04:32 UTC